LakshmananKrishnamurtiMD

Pediatric Hematology & Oncology • Trumbull, CT

Professor, Pediatrics, Yale School of Medicine

Join to view full profile

Dr. Krishnamurti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Krishnamurti's full profile

Already have an account?

Office
5520 Park Avenue
Yale New Haven Children's Hospital Pediatric Specialty Center
Trumbull, CT 06611

Summary

Dr. Lakshmanan Krishnamurti is a pediatric hematologist/oncologist in New Haven CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from Armed Forces Medical College Pune and has been in practice 37 years. He is experienced in platelet disorders, myeloproliferative disorders, aplastic anemia, hematopoietic stem cell transplantation, and bone marrow transplantation. He has more than 100 publications and over 500 citings.

Education & Training

University of MinnesotaResidency, Pediatrics, 1995 - 1998
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1994 - 1997
ArMed Forces Medical College PuneClass of 1980

Certifications & Licensure

CT State Medical License 2021 - 2025
PA State Medical License 2001 - 2024
GA State Medical License 2014 - 2023
MN State Medical License 1998 - 2002
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014

Clinical Trials

PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease
Unknown status
Phase 1
A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen Start of enrollment: 2002 Jun 01
Completed
Not Applicable
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases Start of enrollment: 2001 Dec 01
Recruiting
Phase 1, Phase 2
Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease Start of enrollment: 2012 Mar 01
Completed
Phase 2
Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients Start of enrollment: 2015 Apr 08
Completed
Phase 2
Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow Start of enrollment: 2019 Jul 10
Completed
Phase 2
Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease Start of enrollment: 2017 Dec 21
Withdrawn
Phase 1
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease Start of enrollment: 2018 Aug 03
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Sickle cell disease in India: the journey and hope for the future.
Kalpna Gupta, Lakshmanan Krishnamurti, Dipty Jain
Hematology. American Society of Hematology. Education Program. 2024-12-06
Haematopoietic stem-cell transplantation for sickle cell disease in low-income and middle-income countries: the experience in India.
Vineeta Gupta, Lakshmanan Krishnamurti
The Lancet. Haematology. 2024-11-01
Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease.
Mark C Walters, Mary Eapen, Yiwen Liu, Fuad El Rassi, Edmund K Waller
Blood Advances. 2024-10-29

Abstracts/Posters

A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Pr...
Lakshmanan Krishnamurti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Associated Co-Morbidities, Healthcare Utilization, and Mortality in Hospitalized Children and Adults with Hemophilia in the United States: Updated Nationally Represent...
Lakshmanan Krishnamurti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Transcranial Doppler Screening in Children with Sickle Cell Anemia Is Feasible in Central India and Reveals High Risk of Stroke
Lakshmanan Krishnamurti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the...
Lakshmanan Krishnamurti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Exploring the Drivers of Potential Clinical Benefit in Initial Patients Treated in the Hgb-206 Study of Lentiglobin for Sickle Cell Disease (SCD) Gene Therapy
Lakshmanan Krishnamurti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Resolution of Sickle Cell Disease Manifestations in Patients Treated with Lentiglobin Gene Therapy: Updated Results from the Phase 1/2 Hgb-206 Group C Study
Lakshmanan Krishnamurti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Preliminary Results of a Phase 1/2 Clinical Study of Zinc Finger Nuclease-Mediated Editing of BCL11A in Autologous Hematopoietic Stem Cells for Transfusion-Dependent B...
Lakshmanan Krishnamurti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Disease Modification in Sickle Cell Disease: Mechanisms, Advances and Clinical Implications
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)Cl...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Vaccination Adherence in Pediatric Patients Post-Hematopoietic Stem Cell Transplant
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Outcomes for Initial Patient Cohorts with up to 33 Months of Follow-up in the Hgb-206 Phase 1 Trial
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Join now to see all

Press Mentions

Yale New Haven Children’s Hospital Appoints Chief of Pediatric HematologyAugust 29th, 2021
Lakshmanan Krishnamurti Named Chief of Pediatric Hematology, Oncology, and Bone Marrow Transplant at Yale New Haven Children’s Hospital and Smilow Cancer HospitalJuly 27th, 2021
5 Oncologists on the MoveJuly 13th, 2021
Join now to see all